Bristol Myers to buy Cambridge startup Orbital Therapeutics, building out cell therapy pipeline – The Boston Globe
Bristol Myers Squibb said Friday that it would buy Cambridge startup Orbital Therapeutics for $1.5 billion in cash, the latest…
Bristol Myers Squibb said Friday that it would buy Cambridge startup Orbital Therapeutics for $1.5 billion in cash, the latest…
A sports activity inspired by Mexico, an innovative idea to upgrade lighting systems, and health supplements to boost gut health…
Indonesian AI-based Korean language learning startup KoreanMate has entered a new phase of its growth strategy by partnering with Chungbuk…
The University of South Florida is taking a bold step to bridge academic innovation with real-world startup application through a…